These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33920869)

  • 41. Electronic health records to facilitate continuous detection of familial hypercholesterolemia.
    Pepplinkhuizen S; Ibrahim S; Vink R; Groot B; Stroes ESG; Bax WA; Cornel JH
    Atherosclerosis; 2020 Oct; 310():83-87. PubMed ID: 32927124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary treatment for familial hypercholesterolaemia.
    Poustie VJ; Rutherford P
    Cochrane Database Syst Rev; 2001; (2):CD001918. PubMed ID: 11406018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of familial hypercholesterolemia in patients from a general practice database.
    Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
    Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome.
    Hauguel-Moreau M; Aïdan V; Hergault H; Beauchet A; Pépin M; Prati G; Pillière R; Ouadahi M; Josseran L; Rodon C; Rabès JP; Charron P; Dubourg O; Massy Z; Mansencal N
    Arch Cardiovasc Dis; 2022 Feb; 115(2):87-95. PubMed ID: 35123917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Gulizia MM; Maggioni AP; Abrignani MG; Bilato C; Mangiacapra F; Sanchez FA; Piovaccari G; Montagna L; Marini M; De Biasio M; Averna M; Casula M; Colivicchi F; Fabbri G; Lucci D; Zampoleri V; Catapano AL;
    Atherosclerosis; 2020 Sep; 308():32-38. PubMed ID: 32823190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
    Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
    Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study.
    Casula M; Olmastroni E; Pirillo A; Catapano AL; ; ; ; ; ;
    Atherosclerosis; 2018 Oct; 277():413-418. PubMed ID: 30270079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study.
    Langsted A; Kamstrup PR; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):577-87. PubMed ID: 27185354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse-led clinics.
    Green P; Neely D; Humphries SE;
    J Eval Clin Pract; 2016 Jun; 22(3):341-8. PubMed ID: 26608940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner.
    Bell DA; Hooper AJ; Edwards G; Southwell L; Pang J; van Bockxmeer FM; Watts GF; Burnett JR
    Atherosclerosis; 2014 Jun; 234(2):469-72. PubMed ID: 24814411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving the identification of patients with a genetic diagnosis of familial hypercholesterolaemia in primary care: A strategy to achieve the NHS long term plan.
    Ingoe L; Potter A; Musson S; Neely D; Pilkington G; Allen AJ; Reay D; Luvai A; McAnulty C; Camm N; Berry I; Nichols J; Forbes G; Newton J; Carey PE
    Atherosclerosis; 2021 May; 325():38-45. PubMed ID: 33892327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India.
    Sawhney JPS; Prasad SR; Sharma M; Madan K; Mohanty A; Passey R; Mehta A; Kandpal B; Makhija A; Jain R; Mantri RR; Vivek BS; Manchanda SC; Verma IC
    Indian Heart J; 2019; 71(2):118-122. PubMed ID: 31280822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre.
    Gray J; Jaiyeola A; Whiting M; Modell M; Wierzbicki AS
    Heart; 2008 Jun; 94(6):754-8. PubMed ID: 17575326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database.
    Guglielmi V; Bellia A; Pecchioli S; Medea G; Parretti D; Lauro D; Sbraccia P; Federici M; Cricelli I; Cricelli C; Lapi F
    Int J Cardiol; 2016 Nov; 223():701-705. PubMed ID: 27568993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
    Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
    Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
    Farnier M; Civeira F; Descamps O;
    Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records.
    Iyen B; Qureshi N; Weng S; Roderick P; Kai J; Capps N; Durrington PN; McDowell IF; Soran H; Neil A; Humphries SE
    Atherosclerosis; 2020 Dec; 315():131-137. PubMed ID: 33187671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility and cost of FH cascade screening in Belgium (BEL-CASCADE) including a novel rapid rule-out strategy.
    Descamps OS; Rietzschel E; Laporte A; Buysschaert I; De Raedt H; Elegeert I; Chenot F; Lengele JP; Carlier S; Vanderheeren P; Lienart F; Friart A; Guillaume M; Vandekerckhove H; Maudens G; Mertens A; van de Borne P; Bondue A; De Sutter J
    Acta Cardiol; 2021 May; 76(3):227-235. PubMed ID: 32964780
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.